Zimmer Holdings says the FDA cleared its iAssist Knee system for helping surgeons accurately position knee implants
Zimmer (NYSE:ZMH) said it won 510(k) clearance from the FDA for its iAssist Knee personalized guidance system for knee replacements.
An Australian judge approves DePuy Orthopaedics' knee implant settlement, granting patients compensation beginning at $32,500 apiece, going as high as $68,200 per patient.
An Australian judge approved Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics' lawsuit settlement, in which the company will pay between approximately $32,500 (A$31,000) and $68,200 (A$65,000) to each patient who received a defective knee implant.
Blue Belt Technologies enters the robot-assisted surgery market with an FDA win NavioPFS Surgical System for partial knee replacement.
The U.S. robot-assisted surgery space added a new player this week with FDA clearance for Blue Belt Technologies' NavioPFS orthopedic surgery system.
The Pittsburgh, Pa.-based device maker won clearance with indication for partial knee replacement, a procedure generally performed using manual instruments, the company noted.
ConforMIS releases its next-generation iTotal G2 knee replacement system, the only patient-specific total knee replacement device left on the market.
Orthopedics devices maker ConforMIS released the latest iteration of its iTotal G2 total knee replacement system, the only such device on the market today, according to the company.
The G2 represents a years' worth of surgeon feedback on the original design, which the FDA cleared in January 2011 and was released to a limited group of surgeons a few months later, according to a press release.
Rates of total knee replacement surgeries have doubled since 1991 and post-procedure complications are on the rise, leading some researchers to wonder whether physicians are playing fast and loose with knee patients.
A dramatic increase in surgical knee replacement has some researchers concerned that the procedure may be misused.
The ratio of Medicare patients undergoing total knee arthroplasty (TKA) jumped 99.2% between 1991 and 2010, from 31.2 procedures per 10,000 Medicare enrollees to 62.1 procedures per 10,000 enrollees, according to a new study.
"The growth in TKA should prompt consideration of whether too many (or too few) of these procedures are being performed both in aggregate and among key patient subgroups defined by race, sex, or age," the authors wrote.
A jury decides in Zimmer's favor that the Gel-One arthritis knee pain treatment doesn't infringe on Genzyme's patents.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.